临床特征和诊断途径的临床特征和诊断途径的概述
Brianna N Brun1, Neil Camarta2, Nick Johnson3
1Department of Neurology, University of Rochester Medical Center, New York, USA.
Neuromuscular disorders : NMD
|March 4, 2026
概括
面骨骨缩症 (FSHD) 是一种由DUX4基因表达引起的渐进性肌肉疾病,影响各种肌肉和系统. 研究正在推进,许多临床试验为未来疾病修饰治疗提供了希望.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 肌肉发育不良的研究 肌肉发育不良研究
背景情况:
- 面骨骨缩症 (FSHD) 是一种普遍存在的肌肉缩症.
- 通常在15-30岁之间出现,与异常的DUX4表达有关.
- 它的特征是渐进的,不对称的肌肉衰弱 (面部,肩膀,上臂).
研究的目的:
- 为了提供FSHD的全面概述.
- 突出诊断标准和管理策略.
- 讨论当前的研究和治疗试验格局.
主要方法:
- 病史和体检是关键的诊断工具.
- 基因检测证实了FSHD的诊断.
- 肌肉活检和成像用于试验中的生物标志物.
主要成果:
- FSHD呈现出显著的表型变异性.
- 多系统性参与包括听力损失,视力问题,呼吸系统虚弱,疼痛和疲劳.
- 目前没有批准的疾病修饰疗法.
结论:
- FSHD的管理是多学科的,重点是缓解症状和系统性并发症.
- 目前正在努力提高试验准备度和患者健康状况.
- 许多正在进行的临床试验为未来有效治疗提供了希望.
相关概念视频
Disorders of the Skeletal Muscle
2.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.1K
Myasthenia Gravis: Diagnostic Tests
2.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K
Myasthenia Gravis: Overview and Treatment
3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
586
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
586
Satellite Stem Cells and Muscular Dystrophy
2.5K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.5K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K


